Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Other Liabilities

Adverum Biotechnlgs Other Liabilities Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Other Liabilities from 2013 to 2020.
  • Adverum Biotechnlgs Other Liabilities for the quarter ending June 06, 2020 was $0m a -83.17% decrease of 0m year over year
  • Adverum Biotechnlgs Other Liabilities for the last 12 months ending June 06, 2020 was $0m a -83.17% decrease of 0m year over year
  • Adverum Biotechnlgs Annual Other Liabilities for 2019 was $0m a -2,835.42% decrease of -1m from 2018
  • Adverum Biotechnlgs Annual Other Liabilities for 2018 was $1m a -378.78% decrease of -5m from 2017
  • Adverum Biotechnlgs Annual Other Liabilities for 2017 was $7m a -33.61% decrease of -2m from 2016
Other Balance Sheet Metrics:
  • Adverum Biotechnlgs Total Assets for the quarter ending September 09, 2018 was $226m a 10.62% increase of 24m year over year
  • Adverum Biotechnlgs Total Equity for the quarter ending September 09, 2018 was $216m a 14.63% increase of 32m year over year
View Chart On Koyfin

Quarterly ADVM Other Liabilities Data

06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$1m
09/2018$0m
06/2018$2m
03/2018$2m

Annual ADVM Other Liabilities Data

2019$0m
2018$1m
2017$7m
2016$9m
2015$5m
2014$7m
2013$0m
2012$0m